Toward the end of trading Monday, the Dow traded down 0.04 percent to 15,788.01 while the NASDAQ surged 0.42 percent to 4,143.17. The S&P also fell, dropping 0.05 percent to 1,797.53.
Top Headline
Hasbro (NASDAQ: HAS) reported downbeat fourth-quarter results. Hasbro's quarterly net earnings dropped to $129.8 million, or $0.98 per share, versus $130.3 million, or $0.99 per share, in the year-ago period. Excluding special items, it earned $1.12 per share, versus analysts' estimates of $1.22 per share Its sales came in flat at $1.28 billion, versus estimates of $1.30 billion.
Top 10 Tech Companies To Invest In Right Now: Hutchinson Technology Inc (HTCH)
Hutchinson Technology Incorporated (HTI), incorporated on October 29, 1965, is a global technology manufacturer. The Company is a supplier of suspension assemblies for hard disk drives. The Company operates in two segments: the Disk Drive Components Division and the BioMeasurement Division. The Company manufactures suspension assemblies for all sizes and types of hard disk drives. Suspension assemblies are components of disk drives that hold the read/write heads in position above the spinning magnetic disks.
The Company categorize its products as either suspension assemblies or other revenue, which consists primarily of revenue outside of the disk drive industry for precision component manufacturing, tool design, tool build and metrology, suspension assembly components, reimbursement for disk drive industry-related engineering services and specific disk drive program capacity and biomeasurement products. During the year ended September 29, 2013, the Company shipped 404 million suspension assemblies of all types, supplying all manufacturers of disk drives and head-gimbal assemblers.
The Company competes with Nihon Hatsujo Kabusikigaisha, Magnecomp Precision Technology Public Company Limited, NAT Peripheral (H.K.) Co., Ltd., Nitto Denko Corporation and Dai Nippon Corporation.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 electronic component player that's starting to move within range of triggering a big breakout trade is Hutchinson Technology (HTCH), which is a technology manufacturer that creates value by developing solutions to critical customer problems. This stock has been on fire during 2013, with shares up a whopping 75%.
If you take a look at the chart for Hutchinson Technology, you'll notice that this stock has been finding significant buying interest over the last two months, whenever it has pulled back to around $3.30 to $3.20 a share. This pattern could be signaling that shares of HTCH are forming a major bottoming chart pattern if those levels can hold as support. Shares of HTCH are now starting to flirt with its 50-day moving average at $3.56 a share. That move is starting to push the stock within range of triggering a big breakout trade above a key downtrend line.
Market players should now look for long-biased trades in HTCH if it manages to break out above its 200-day moving average of $3.65 a share and then once it clears more overhead resistance levels at $3.89 to $4.13 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 392,134 shares. If that breakout triggers soon, then HTCH will set up to re-test or possibly take out its next major overhead resistance levels at $4.75 to $5.50 a share, or even $6 a share.
Traders can look to buy HTCH off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.37 or at $3.17 a share. One can also buy HTCH off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top Consumer Service Companies To Invest In Right Now: HeartWare International Inc (HTWR)
Heartware International, Inc. (HeartWare), incorporated on June 25, 2010, develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure. The HeartWare Ventricular Assist System (the HeartWare System), which includes a ventricular assist device (VAD), or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients in the advanced stage of heart failure. The core of the HeartWare System is a continuous flow blood pump, the HVAD Pump, which is a full-output device capable of pumping up to 10 liters of blood per minute. The HeartWare System is designed to be implanted adjacent to the heart, avoiding the abdominal surgery generally required to implant similar devices. In August 2012, it acquired World Heart Corporation. As of December 31, 2012, the HeartWare System has been implanted outside of the United States at approximately 168 health care sites in 28 countries. In December 2013, HeartWare International Inc acquired CircuLite, Inc.
Proprietary Pump Technology
The HeartWare System is full-output centrifugal pump designed to be implanted in the chest, directly adjacent to the heart. At the core of the Company�� technology platform is its hybrid system for suspending the impeller, which is the only moving part within the pump. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller, which circulates a cushion of
blood. Once power is applied to the device and the impeller begins to rotate, there are no points of mechanical contact within the pump, thus providing a completely wearless pumping system.
The HeartWare System
The HeartWare System consists of the HVAD Pump, a small, permanently implantable VAD, patient accessories and surgical tools. The HVAD Pump is capable of generating up to 10 liters of blood flow per minute. With a displaced v! olume of only 50 cubic centimeters and a mass of 140 grams, the HVAD Pump is the only full-output pump implantable in the pericardial space, directly adjacent to the heart. It is also the only pump designed to be implanted above the diaphragm in all eligible patients.
The HeartWare MVAD
The miniaturized ventricular assist device (MVAD) is a miniaturized blood pump intended for chronic heart failure patients. The device is a full-output axial flow pump with a fully suspended rotor and a displacement volume approximately one-third that of the HVAD Pump.
The Company competes with Thoratec Corporation, Jarvik Heart, MicroMed Technology, Inc, Berlin Heart AG, Terumo Heart, Inc., Sunshine Heart, Inc and CircuLite, Inc., Evaheart Medical USA, Inc.
Advisors' Opinion:- [By Todd Campbell]
Competing for heart pump market share
Abiomed's products provide circulatory support for up to six hours and are designed for use in cardiac cath labs or during heart surgery, but competitors Thoratec (NASDAQ: THOR ) and Heartware (NASDAQ: HTWR ) target the intermediate- and long-term-use market instead. - [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
HeartWare International Inc.(HTWR) said it received a warning letter from the U.S. Food and Drug Administration, citing concerns about procedures for validating device design and other issues.
- [By Lauren Pollock]
Medical device company HeartWare International Inc.(HTWR) issued a revenue forecast that fell short of market expectations.
Intrepid Potash Inc.(IPI), the largest potash producer in the U.S., plans to cut its workforce by 7% and cut executive compensation as part of a plan to trim costs in reaction to weaker prices for the fertilizer ingredient.
Top Consumer Service Companies To Invest In Right Now: Albany Molecular Research Inc.(AMRI)
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States, Europe, and Asia. The company offers a range of drug discovery services, including assay development and design, screening, screening library, natural product, medicinal chemistry, computer-aided drug discovery, in vitro ADMET, and bioanalytical services. It also provides chemical development services consisting of process research and development, custom synthesis, process safety assessment, scale-up capabilities, high potency and controlled substances, analytical services, preformulation services and physical characterization, preparative chromatography, IND support services, fermentation development and optimization, and building blocks collection and database services. In addition, the company offers chemical synthesis and manufacturing services. It manufactures active pharmaceutical ingredients (APIs)and advanced intermediate s. Further, the company provides contract manufacturing services in sterile syringe and vial filling for small molecule drug products and biologicals. Additionally, it offers formulation services, including neat API or pharmaceutical blend in capsules; PIB for solution and suspension; blending and sieving; milling; tableting; rheology; roller compaction; wet granulation; and fluid bed processing, including wurster coating; and associated analytical testing services for dosage formulation products, as well as provides analytical services, such as impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; analytical and preparative supercritical fluid chromatography; preparative chromatography; good laboratory practices bioanalytical services; and regulatory support/quality assurance services. The company was founded in 1991 and is based in Albany, New York.
Advisors' Opinion:- [By GuruFocus]
George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated
- [By Jake L'Ecuyer]
Among the sector stocks, Albany Molecular Research (NASDAQ: AMRI) was down more than 13 percent, while Sangamo Biosciences (NASDAQ: SGMO) tumbled around 6 percent.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV).
Top Consumer Service Companies To Invest In Right Now: Stewart Enterprises Inc.(STEI)
Stewart Enterprises, Inc., through its subsidiaries, provides funeral and cemetery products and services in the death care industry in the United States and Puerto Rico. The company also offers a range of funeral merchandise and services, as well as cemetery property, cremation, merchandise, and services. Its funeral homes provide various services and products, including the family consultation, removal and preparation of remains, usage of funeral home facilities for visitation, worship and funeral services, transportation services, flowers, and caskets. The company also sells cemetery property and related merchandise, which includes lots, lawn crypts, family and community mausoleums, monuments, markers, and burial vaults; and provides burial site openings and closings and inscriptions. In addition, it maintains cemetery grounds under cemetery perpetual care contracts and local laws. As of January 31, 2011, the company owned and operated 218 funeral homes and 141 cemeterie s. Stewart Enterprises, Inc. was founded in 1910 and is based in Jefferson, Louisiana.
Advisors' Opinion:- [By Chris Katje]
Service Corporation (SCI), the largest funeral home operator in the United States, made news last week with its large acquisition of Stewart Enterprises (STEI). The acquisition was well received by investors, as shares rose 8% on the day of the announcement. Together, the two companies will see huge cost savings advantages and a backlog that is currently undervalued.
Top Consumer Service Companies To Invest In Right Now: Dyax Corp.(DYAX)
Dyax Corp., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel biotherapeutics for unmet medical needs in the United States. The company utilizes its proprietary drug discovery technology, known as phage display, to identify antibody, small protein, and peptide compounds. It markets KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. Dyax Corp. also provides KALBITOR Access program, which offers treatment support service for patients with HAE and their healthcare providers. In addition, the company is developing a pipeline of 17 product candidates, including 4 product candidates in Phase III clinical trial, 4 product candidates in Phase II clinical trial, and 9 product candidates in Phase 1 clinical trial for the treatment of atherosclerosis, multiple sclerosis, and oncology diseases. Further, it provides library licenses to use its phage display libr aries in connection with their internal therapeutic development programs; performs funded research for various collaborators; and offers patent licenses to other biopharmaceutical and pharmaceutical companies to use its phage display patents to discover and develop biologic compounds for use in specified fields. The company has strategic partnership agreement with Defiante Farmaceutica S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia; an agreement with CMIC Co., Ltd to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other angioedema indications in Japan; and an license and collaboration agreement with Cubist Pharmaceuticals, Inc. to develop and commercialize the formulation of ecallantide for the reduction of blood loss during surgery in North America and Europe. Dyax Corp. was founded in 1989 and is headquartered in Cambri dge, Massachusetts.
Advisors' Opinion:- [By Keith Speights]
The bottom dropped out
Shares of Dyax (NASDAQ: DYAX ) plunged 37% this week. Why did the bottom drop out for this stock? Horrendous first-quarter earnings.
Top Consumer Service Companies To Invest In Right Now: Theragenics Corporation(TGX)
Theragenics Corporation operates as a medical device company serving the cancer treatment and surgical products markets primarily in the United States and Europe. It operates through two segments, Surgical Products and Brachytherapy Seed. The Surgical Products segment manufactures, markets, and sells disposable devices primarily utilized in surgical procedures. It offers wound closure products, including sutures, needles, and other surgical products; vascular access products comprising introducer sheaths, guidewires, and accessories; and specialty needles consisting of coaxial, biopsy, brachytherapy, guidewire introducer, spinal, and disposable veress, as well as access trocars and other needle-based products. This segment?s products are used in various markets and applications, such as interventional cardiology and radiology, vascular surgery, orthopedics, plastic surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. The Brachytherapy See d segment manufactures, markets, and sells TheraSeed and I-Seed, which are FDA-cleared devices for treatment of solid localized tumors and localized prostate cancer. The company sells its products primarily to physicians, hospitals and other healthcare providers, original equipment manufacturers, and to a network of distributors. Theragenics Corporation was founded in 1981 and is based in Buford, Georgia.
Advisors' Opinion:- [By James E. Brumley]
I hate to be the one to say I told you so, but, I told you so. Back on February 26th I suggested IsoRay, Inc. (NYSEMKT:ISR) shares were a budding breakout play. The 48% rally that's played out for ISR in the meantime unfurled right on cue. While overbought in the very short run, this small cap stock looks like it's earning the right to be compared to the likes of bigger brothers in the cancer-treatment space... names like Roche Holding Ltd. (OTCMKTS:RHHBY) or Theragenics Corporation (NYSE:TGX).
Top Consumer Service Companies To Invest In Right Now: Syntroleum Corporation(SYNM)
Syntroleum Corporation and its subsidiaries engage in commercializing and licensing its Syntroleum technologies to produce synthetic liquid hydrocarbons. Its Syntroleum process involves conversion of carbon containing material into synthesis gas; and conversion of the synthesis gas or coal-derived or biomass-derived syngas into hydrocarbons. The company also develops the Synfining Process technology for the conversion of Fischer-Tropsch wax into various products, including diesel fuels, jet fuels, lubricants, naphtha, and other materials. In addition, it offers the Bio-Synfining technology, a second generation renewable fuels technology that is feedstock flexible, including the use of vegetable oils, fats, fatty acids, and greases. Syntroleum Corporation was founded in 1984 and is based in Tulsa, Oklahoma.
Advisors' Opinion:- [By John Udovich]
As a new Government Accountability Office (GAO) report comes out about wasteful spending on biofuels, small cap renewable biofuel stock Gevo, Inc (NASDAQ: GEVO) reported earnings that came in below expectations -�meaning its worth taking a closer look at the GAO report, the stock and the performance of KiOR Inc (NASDAQ: KIOR), Solazyme Inc (NASDAQ: SZYM) and Syntroleum Corp (NASDAQ: SYNM).
- [By John Udovich]
Small cap biofuel or synthetic fuel stocks Gevo, Inc (NASDAQ: GEVO), KiOR Inc (NASDAQ: KIOR), Solazyme Inc (NASDAQ: SZYM) and Syntroleum Corp (NASDAQ: SYNM) all seem to have been seeing some trading action in recent days���meaning its worth taking a closer look at all four�before taking a look at their rather dismal�long term performance while noting that none are yet profitable:
No comments:
Post a Comment